BackAIM ImmunoTech Overview

AIM ImmunoTech Accounts Payable

Track AIM ImmunoTech's accounts payable ($480K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$480000.00
↓ 93.42% YoYΔ $-6.82M vs prior year quarter

Peer trimmed avg / median

Loading

AIM ImmunoTech Accounts Payable History

Loading

AIM ImmunoTech vs. peers: Accounts Payable Comparison

Loading

AIM ImmunoTech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AIM ImmunoTech (AIM) FAQ

AIM ImmunoTech (AIM) currently reports a accounts payable of $480K as of June 2026. That compares with $7.3M in the prior-year period — down 93.4% year over year. Use the charts on this page to explore AIM ImmunoTech's accounts payable history and peer comparisons.

AIM ImmunoTech's accounts payable decreased from $7.3M to $480K — a 93.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AIM ImmunoTech reported $480K in accounts payable as of June 2026. That compares with $7.3M in the prior-year period — down 93.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $480K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AIM ImmunoTech, and consider following AIM for alerts when major investors trade the stock.

AIM ImmunoTech is classified in the Healthcare sector. On accounts payable, it currently shows $480K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AIM with unrelated industries.